Fig. 5From: A novel 7 RNA-based signature for prediction of prognosis and therapeutic responses of wild-type BRAF cutaneous melanomaa Complex heatmap of 24 sorts of immune cells of WT Bf-CM patients, accompanied by signature-related risk groups, immune infiltration, age, stage, gender and vital status. b Expression of immune markers in high and low risk groups. c Predicted IC50 of various anti-cancer drugs. The p values were calculated using Wilcoxon rank-sum testBack to article page